<DOC>
	<DOC>NCT02867176</DOC>
	<brief_summary>This is a prospective, randomized, single blind study. Patients enrolled in the study were randomly assigned to a ketorolac or a gabapentin group for pain control. Different pain scores and variables will be evaluated, along with others side effects variables.</brief_summary>
	<brief_title>Pain Management in Corneal Collagen Crosslinking for Keratoconus</brief_title>
	<detailed_description>This is a prospective, randomized, single blind study. Patients enrolled in the study were randomly assigned to the ketorolac or gabapentin group. The gabapentin (Neurontin, Pfizer, Mexico) group was instructed to take one 300-mg capsule the night before surgery and 1 capsule every 8 hours on the day of surgery and for the first 3 postoperative days. The ketorolac group (Dolac, Siegfried Rhein, Mexico) was instructed to take their 10-mg tablets every 8 hours on the day of surgery and for the first 3 postoperative days. Different pain scores and variables will be evaluated, along with others side effects variables.</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>Patients with keratoconus older than 18 years with documented bilateral keratometric progression in the previous 6 to 12 months. Previous ocular or systemic diseases that could affect epithelial healing; use of topical or systemic nonsteroidal antiinflammatory drugs, or chronic use of any other pain medication, pregnancy and allergy to the drugs of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>